Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy
  • Therapeutic Opportunities
    • Overview
    • Sepsis
    • Virus-induced Cytokine Storm
    • Bacteria-induced Cytokine Storm
    • Acute Respiratory Distress Syndrome
    • Hepatic Encephalopathy
    • Bridge-To-Liver Transplant
  • News & Media
    • Press Releases
    • Presentations
    • Resources
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jan 26, 2021 8:30am EST

Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs

Jan 19, 2021 8:30am EST

Recent Milestone Achievements of Sigyn Therapeutics Discussed During CEO Interview

Jan 12, 2021 8:30am EST

Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies

Jan 06, 2021 8:30am EST

Sigyn Therapeutics™ Reports Results of Pilot Study to Address Inflammatory CytoVesicles

Dec 01, 2020 8:45am EST

Sigyn Therapeutics™ Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma

Nov 02, 2020 7:30am EST

Sigyn Therapeutics (SIGY) CEO Note: Rethinking the Treatment of Sepsis and Other Life-Threatening Inflammatory Conditions

Oct 19, 2020 4:30pm EDT

Sigyn Therapeutics Announces Completion of Merger with Reign Resources

Aug 26, 2020 4:30pm EDT

Reign Resources Corporation and Sigyn Therapeutics Announce Definitive Merger Agreement

RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2021 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap